What's new in ESMO guidelines? - report from ESMO 2025

Medical Digest & Congress Report
14/11/2025 6 min

Listen "What's new in ESMO guidelines? - report from ESMO 2025"

Descargar episodio Ver en sitio original

Episode Synopsis

Professor Emanuela Romano explains what's new in ESMO guidelines on hepatocellular carcinoma, cutaneous melanoma, Hodgkin Lymphomas and early stage and locally advanced non-small cell lung cancers at the ESMO Congress 2025.Video: https://medicaldigest.org/scientific-contents/interview:whats-new-esmo-guidelines

More episodes of the podcast Medical Digest & Congress Report

Immuno-oncology biomarkers in locally advanced HNSCC - lessons from the KeyNote-689 trial - report from ESMO 2025 14/11/2025
Novelties of the treatment of colon cancer at ESMO 2025 14/11/2025
How to PROC - Breaking the Wall of Platinum-Resistance in Ovarian Cancer - report from ESMO 2025 14/11/2025
IMvigor011: A Phase 3 Trial of ctDNA-Guided Adjuvant Atezolizumab versus Placebo in MIBC - report from ESMO 2025 14/11/2025
T-DXd Effective for Treating HER2+ Advanced or Metastatic Breast Cancer, Regardless of Treatment History, HR Status, or PIK3C Mutations - report from ESMO 2025 14/11/2025
DYNAMIC-III trial results: ctDNA blood test is a powerful tool to guide treatment choices for people with advanced colon cancer - report from ESMO 2025 13/11/2025
Overcoming Therapeutic Challenges in High-risk Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Approach - report from ESMO 2025 13/11/2025
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials - report from ESMO 2025 13/11/2025
Durvalumab in Combination with BCG for BCG-Naïve High-Risk NMIBC: Final Analysis of the Phase 3, Open-Label, Randomized POTOMAC Trial - report from ESMO 2025 13/11/2025
Treatment Landscape in Resectable LA HNSCC - report from ESMO 2025 13/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA